Histologic Transformation in NSCLC with PD-1 therapy
J Thorac Oncol
.
2017 Sep;12(9):e133-e134.
doi: 10.1016/j.jtho.2017.04.026.
Epub 2017 May 10.
Authors
Misako Nagasaka
1
,
Rahul S Pansare
2
,
Eman Abdulfatah
3
,
Hui Guan
4
,
Paul Tranchida
4
,
Shirish M Gadgeel
5
Affiliations
1
Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan.
2
Department of Infectious Disease, Wayne State University, Detroit, Michigan.
3
Department of Pathology, Wayne State University, Detroit, Michigan.
4
Department of Surgical Pathology, Detroit Medical Center/Karmanos Cancer Institute, Detroit, Michigan.
5
Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan. Electronic address: sgadgeel@med.umich.edu.
PMID:
28502723
DOI:
10.1016/j.jtho.2017.04.026
No abstract available
Publication types
Case Reports
MeSH terms
Aged
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Humans
Male
Programmed Cell Death 1 Receptor / therapeutic use*
Substances
Programmed Cell Death 1 Receptor